The nonprofit scientific research organization IAVI and Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant screenings are soon to start for a Phase I ...
Leia Inc., the leading 3D experience platform leveraging proprietary Nanotechnology and AI to democratize the Metaverse, partnered with Anatomage Inc, a market leader in medical imaging technology, to enable a cost-effective 3D medical education solution ...
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National Institutes of Health to develop small molecule antiviral therapeutics to prevent pandemics. The center will ...
Popular Posts
